Safran SA (OTCMKTS:SAFRY – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 53,400 shares, a growth of 44.3% from the August 31st total of 37,000 shares. Based on an average daily volume of 391,500 shares, the short-interest ratio is currently 0.1 days.
Safran Trading Down 1.5 %
Shares of SAFRY traded down $0.93 during trading hours on Friday, hitting $59.44. The company had a trading volume of 69,778 shares, compared to its average volume of 128,196. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.88 and a quick ratio of 0.61. The business has a fifty day moving average of $54.83 and a 200-day moving average of $55.37. Safran has a 12 month low of $37.54 and a 12 month high of $60.57.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on SAFRY shares. Royal Bank of Canada upgraded Safran to a “moderate buy” rating in a report on Wednesday, September 11th. Citigroup upgraded Safran from a “neutral” rating to a “buy” rating in a research note on Thursday, June 27th.
Safran Company Profile
Safran SA, together with its subsidiaries, engages in the aerospace and defense businesses worldwide. The company operates through three segments: Aerospace Propulsion; Aircraft Equipment, Defense and Aerosystems; and Aircraft Interiors. The Aerospace Propulsion segment designs, develops, produces, and markets propulsion and mechanical power transmission systems for commercial aircraft, military transport, training and combat aircraft, civil and military helicopters, satellites, and drones; and offers maintenance, repair, and overhaul (MRO) services, as well as sells spare parts.
Recommended Stories
- Five stocks we like better than Safran
- The Risks of Owning Bonds
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 9/23 – 9/27
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Safran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safran and related companies with MarketBeat.com's FREE daily email newsletter.